Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente CLINICAL CANCER RESEARCH

Tipo Año Título Fuente
Artículo2024Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC TrialCLINICAL CANCER RESEARCH
Artículo2024Spatially preserved multi-region transcriptomic subtyping and biomarkers of chemoimmunotherapy outcome in extensive-stage small cell lung cancer.CLINICAL CANCER RESEARCH
Editorial2023Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238CLINICAL CANCER RESEARCH
Artículo2023Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials.CLINICAL CANCER RESEARCH
Artículo2022Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker SubanalysisCLINICAL CANCER RESEARCH
Artículo20215-year outcomes with cobimetinib plus vemurafenib in BRAFV600 mutation⇓positive advanced melanoma: extended follow-up of the coBRIM studyCLINICAL CANCER RESEARCH
Artículo2021Pretreatment tissue TCR repertoire evenness is associated with complete pathologic response in patients with NSCLC receiving neoadjuvant chemoimmunotherapyCLINICAL CANCER RESEARCH
Artículo2020A somatostatin receptor subtype-3 (SST3) peptide agonist shows antitumor effects in experimental models of nonfunctioning pituitary tumorsCLINICAL CANCER RESEARCH
Artículo2020Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGF beta-Induced Breast Cancer MetastasisCLINICAL CANCER RESEARCH
Revisión2020PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical PracticeCLINICAL CANCER RESEARCH
Artículo2019Preclinical efficacy of endoglin-targeting antibody-drug conjugates for the treatment of Ewing sarcomaCLINICAL CANCER RESEARCH
Artículo2019VCAM-1-targeted MRI Enables Detection of Brain Micrometastases from Different Primary TumorsCLINICAL CANCER RESEARCH
Artículo2019Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) PolymorphismsCLINICAL CANCER RESEARCH
Artículo2017The Cargo Protein MAP17 (PDZK1IP1) Regulates the Cancer Stem Cell Pool Activating the Notch Pathway by Abducting NUMBCLINICAL CANCER RESEARCH
Artículo2016Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical TrialCLINICAL CANCER RESEARCH
Artículo2016Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)CLINICAL CANCER RESEARCH
Artículo2015Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal CancerCLINICAL CANCER RESEARCH
Artículo2015Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination with Anti-IGF Signaling AgentsCLINICAL CANCER RESEARCH
Artículo2014Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue OriginsCLINICAL CANCER RESEARCH
Artículo2010MSH6 and MUTYH Deficiency Is a Frequent Event in Early-Onset Colorectal CancerCLINICAL CANCER RESEARCH
Artículo2006Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumorCLINICAL CANCER RESEARCH
Artículo2005Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H : quinone oxidoreductase 1 levelsCLINICAL CANCER RESEARCH
Letter2005Imatinib is not a potential alternative treatment for uterine leiomyosarcomaCLINICAL CANCER RESEARCH
Artículo2004Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell Factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosisCLINICAL CANCER RESEARCH